about
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingSpread of artemisinin resistance in Plasmodium falciparum malariaChanges in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentArtemisinin Resistance in Plasmodium falciparum MalariaPreclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studySpiroindolones, a potent compound class for the treatment of malariaArtemisinin combination therapy for vivax malariaA randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.Comparison of the Performances of Five Primer Sets for the Detection and Quantification of Plasmodium in Anopheline Vectors by Real-Time PCRThe role of early detection and treatment in malaria eliminationHuman ex vivo studies on asexual Plasmodium vivax: the best way forwardPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureGenomic analysis of local variation and recent evolution in Plasmodium vivax.Family planning knowledge, attitudes and practices in refugee and migrant pregnant and post-partum women on the Thailand-Myanmar border - a mixed methods studyRheopathologic Consequence of Plasmodium vivax Rosette FormationTargeting Plasmodium PI(4)K to eliminate malariaGenetic architecture of artemisinin-resistant Plasmodium falciparumVarB: a variation browsing and analysis tool for variants derived from next-generation sequencing dataSelection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina FasoPopulation pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patientsArtemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trialDeployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria InitiativeAdaptive copy number evolution in malaria parasitesA randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancyNovel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistancePopulation genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assayMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studySignificant biochemical, biophysical and metabolic diversity in circulating human cord blood reticulocytesNonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparumEfficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquineCharacterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assayModeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivoDefining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approachSingle Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient SubjectsNeutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug TherapyTreating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar borderA new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genesReply to Meshnick and Hastings et alOptimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia
P50
Q20901697-947B4043-EEEE-4470-924B-6A7210522C9CQ21032481-9DA2E9E2-0074-4391-A79A-A39974F1ACF5Q21032481-E257D989-857A-45B9-B001-0B6FC4837DC6Q21090072-DDDE4EB9-8AA3-4338-902A-67B70B8F0233Q22061852-49907FBF-6F5F-477E-834C-3B234F79248CQ24273364-DCC56945-DF46-4D74-BA8C-2847617D605AQ24598695-F4EF90AA-AD3A-4F00-A07E-F4A8617A55B4Q24606915-66EEBE52-46B1-4172-8434-A1DAD3F0492CQ24622539-BA870387-1F8B-4CE1-8725-3D8D53EC56C6Q24814579-07D92A27-589B-40F0-8323-F525A0166F46Q26315228-C8D49065-A6D8-4479-9654-2A4157036641Q26740068-6B6A25CB-4C4A-4E43-8602-08A6EA956531Q27026814-58581F9A-75AB-49A8-A099-A6AD0160F580Q27027939-FD1952C5-542A-4206-86E0-1CF4BBF86903Q27149930-3E65621B-7AD4-434E-8FED-EEC364FF0FFBQ27302853-32C32E09-4CBD-427A-A229-CE2A4B1ECF1AQ27303570-9AF0ACE0-6C37-4533-9F89-11543F338F89Q27974482-E310A478-44F2-41C2-BB07-0816B03B06B9Q28030935-6B50B77C-53BB-400B-8C63-55B21EBA643FQ28030976-1C18AFED-77E6-4920-AA5B-CDDCBBA71E58Q28125901-8FDD9543-D361-4F86-8161-EDABA9A95CCCQ28469076-2DC1C81C-2CF5-4578-927E-364C44D6CB0BQ28469217-FC6FCE5D-10AF-4993-B41A-82E540C508C6Q28469264-2CC30B6F-ABE0-4654-8B4B-75B9E7F03C4BQ28473933-71033842-3C5A-4121-BC0F-EDB9A2DAF5A7Q28474447-FB8AA8D1-64B0-451B-9E4A-D52E300FAD87Q28478286-8DC146CB-54C0-458A-BDA3-BB59733F3DECQ28478444-48CB170A-3FA3-43FF-B7F2-3215649034AFQ28487636-C81E6F29-DA12-419C-A551-261AD5A5A831Q28534268-DB02BD78-64B7-467F-9F4C-9DEB82386DEDQ28534820-5828E1E1-2736-4C96-96FC-995303FE3411Q28542034-0C84B1AF-5835-4D81-B109-810251876A23Q28544110-CBC6727F-F77B-4E69-A528-0017202E99B7Q28544459-8A83DAA8-A90F-45AF-BD3C-2B704855D390Q28546794-6E07F0A0-D239-42FD-ABC3-879E5053041DQ28550990-9AFDCAF8-0884-4B8E-B3DA-563DB61E9ADFQ28552661-73C72DFC-6E29-4A7A-8812-3E9BE982C6FAQ28563994-C94DA2B9-5A14-435A-A03B-6C5CBD23CECDQ28585693-E3E4E385-30A5-4046-AC40-FFCEE45C48E7Q28595897-CCBE8A74-4C48-4BCF-8A08-B2F2FD738A2A
P50
description
onderzoeker
@nl
physician
@en
name
François H Nosten
@en
François Nosten
@es
François Nosten
@fr
François Nosten
@sl
type
label
François H Nosten
@en
François Nosten
@es
François Nosten
@fr
François Nosten
@sl
altLabel
F H Nosten
@en
F Nosten
@en
F. H. Nosten
@en
F. Nosten
@en
Francois Nosten
@en
François H. Nosten
@en
Nosten F
@en
Nosten F. H.
@en
Nosten F.
@en
Nosten FH
@en
prefLabel
François H Nosten
@en
François Nosten
@es
François Nosten
@fr
François Nosten
@sl
P106
P21
P31
P4124
francois-nosten_64364
P496
0000-0002-7951-0745
P569
2000-01-01T00:00:00Z